Table 5.
Rate of end-stage renal disease or dialysis in patients with monoclonal gammopathy.
| MGUS | SMM | MM | Amyloidosis | NHL | HL | Total∗ | |
|---|---|---|---|---|---|---|---|
| (n = 92) | (n = 7) | (n = 44) | (=16) | (n = 12) | (n = 3) | ||
| CKD stages 1–4-n. (%) | 57 (67.9) | 5 (83.3) | 21 (61.8) | 11 (68.8) | 6 (66.7) | 3 (100) | 103 (67.8) |
| CKD stage 5/dialysis-n. (%) | 27 (32.1) | 1 (16.7) | 13 (38.2) | 5 (31.3) | 3 (33.3) | 0 (3) | 49 (32.2) |
∗Missing data = 13%. CKD, chronic kidney disease; HL, Hodgkin lymphoma; NHL, non-Hodgkin lymphoma; MGUS, monoclonal gammopathy of indeterminate significance; MM, multiple myeloma; SMM, smoldering multiple myeloma.